pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-124-1 |
Genomic Coordinates | chr8: 9903388 - 9903472 |
Description | Homo sapiens miR-124-1 stem-loop |
Comment | miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-124-2 |
Genomic Coordinates | chr8: 64379149 - 64379257 |
Description | Homo sapiens miR-124-2 stem-loop |
Comment | miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-124-3 |
Genomic Coordinates | chr20: 63178500 - 63178586 |
Description | Homo sapiens miR-124-3 stem-loop |
Comment | miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-124-5p | ||||||||||||||||||||||||||||||
Sequence | 14| CGUGUUCACAGCGGACCUUGAU |35 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PSAPL1 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | prosaposin like 1 (gene/pseudogene) | ||||||||||||||||||||
Transcript | NM_001085382 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PSAPL1 | |||||||||||||||||||||
3'UTR of PSAPL1 (miRNA target sites are highlighted) |
>PSAPL1|NM_001085382|3'UTR 1 CCGTGGCTGCCAGAGACCCAGAGCCTGCTAGCGAGGCCCATGAGGTGGGTGCTTTCCCCATCCCCATTTCACAAATGAAA 81 AACTGAAGCTCTGAGGAGGGAGGCTGGGAAGGAGCAGAGCTGAAGTTCAAAACCAAGTATTCCTGATCCCGAAAGCCTCT 161 CTCTTAACAACGGTGCCGCACAGCTTTGCCCTTGAAAGCATCTCTACTGGACCGGAACACACTCATGTGCCCCGCTCCCT 241 GACCCAGCCAAGGCTGCCCTCTCATCTCCAAGGCTGAGATGTTGCCGGTGGTCCCATGAGAGCCTGCCCATGGGCTCAGG 321 TGCCCCTTTACCTTCTGCTGGATGGACATCTGGCTGTGAGCCAGGCTGGGGTCATGGCCGGGGTGAGCGGAGGCAGGGGT 401 GGACGGAGGCTTCGAGGGCCCATCACTAGTAGGGTCATTACCTCTTGCCAACAGCCGGGGGTGGGAGTCTGGGTCTCGCT 481 CAGGCCAGAGCTTCTCAACCTGGAGTCCCTGGGGGTGGCTGCCAAAGGTGTGTATGACAAGCACGTATCCCTGGACATTT 561 CCGGGGAGAGGTCTGGGGCTTTGGTCACATTCTCCAAGGGCTGCTGGGCTTCGGAGCAGTCCCCCCCCATGTCTCAGCCA 641 CTACAGGGTCCCTCTCTCTCCTTGCACCCCAGACCCTCCGCTGCCCTGGTAATGAGCAGAAGGAAAGTCTTGGGGTGTGC 721 TCAAAGTCAGGAGAGCAAAATATGCCAGGCAAAAGCTCCCGGGAAAAGCCGGAGGAGTCTGGGGTGGCCACCGGGATGTG 801 GAGCAGCGAGGGCAAAGACGGTGAACACAGCCCTCCAGCTGTCTGAGCCTCAGTTTTCTAATCTGTAGAATGGGGATGAT 881 CATACCTGCCTCACAAGAATGTTGAGACAATTCACAGAGACGTTCTGGAGCCCCTTTCCCCCGAGACCGGCATTCATGAG 961 TCTGCTGGGACCAGAAAACCCATCTCAGGGGCCCAGCGGGGCACCCAGGAGAGTCTGGCGGTGCAAGCGCTGTATAAACC 1041 ACAAGCGTTCTCCAAATGCCGTGTGCCGTGTTTTTATTCTCAGGGAAGGCGCAGATCCCAGAGCTGCTACAACAGCCTCC 1121 ACCTTACCCTGGTGCCTCCACCTCGCCCCGGTGCCCCCTCTGGCAGAAAGCCTCCGGGGGGGGTTTCCATCTGGGTTCAA 1201 GTGCTCCTGTGGTTTCTGCTCCTGCTGTTTGGCCCCCCTAAGACACTGTGCCCCCTCCAGGAGAGCCCCTGGGCATGACC 1281 CTGCAGTGTCCTTGCAGCTGGCCCAGCATCTGCACGCAGCAGGTGCTCACACATCTGGGAGCCGCACACATGAGTCCCGG 1361 GGGTGGAAGCTGGTATTTCACCTGAGGCCCATGGATTAATTCTCCTCTTGAGTAAGAGGTGCGCCAGGCCTGGATGGACG 1441 GGATGTGAGCGGGTGCTGTTTTCCAAGAGGCCACACCCGAGCTCTTAAGTAAACGTCGCAGACCTGGGCCACCGCCCCAG 1521 GAACACAGGCACACTGGGCCTGAGATTCTGGATGCCTCAGAAGTGGCCCCTATTGGCTGGGCAGGCCTGGGCCCGCTGGG 1601 CAGTCCCACAAAAGATAAGGCCAGCAAGGGGTGGTGGTCGTGCCTGGCCACCGGATGGGCCATGGGAAGGCAGCTCTGCA 1681 CCAGACTCCAAAACACAGGGGCCCGAAGTTGTTGGCCTCAGTATCTGCCTCTTCCCCTGAGACCACCCACCCTCTCCAGG 1761 AGCAGCCCCAGAGGCTCTCTGTCTGCCTGCCGGTAGGTGTTCCCACCTGACACACTCTCTGGGACAGGATGGAGCCATAG 1841 GCCCTCCTCTGGCTTGGCTGTGAGTCGGGAGGATGCCTACCGGGAAGTATGTGTGACATGACCTGAAATCCCCCGACAGG 1921 TCACCTGGGAGAGGCCGGGAGAGGGCAAGCGCCACACCTGCCAGGTGGCCCAGCTCAGCCCACCTGCCCCCACCCCAGAG 2001 CTACCTGCAGTGGGTGGTCAGGGTGGGGTGTCCCCACACCCTCTTCCCTACCCACCCCTTGGGCCTGGGTACCAGCTGCT 2081 CCCACAGACCCACTGAGCACATGCGTCTCCACTAGATGGTTGCCCGTGATGAACGGAGCTCACTGGCCATGACCCCACAG 2161 GCCCAGCTGCACACCCAGGTCATGAGCACGGCCCTGCCCCACCCCCATAGGGGCCCTCTGACCCCTCCACTCACTCATCC 2241 GCCACCAAAGCTGTGGAGGCCTGTGGCAGGGTCTCAGTCACCTCCATCCCCTGTGCCCGGAACCAAGCCCGGAACACAGG 2321 AGGTGCTCTGCAAGTGCTCGTGGGGAGTGGCTGCCTTGGGGTCTAAAGGCAGAGAGGCAGGAGGAGCAAGGGACGGGCCC 2401 ACTGGTGCTGACGGCAGCACCACCATTCAGCACTGAGACTGAGGCTTAAGGAGTCCATCCAAATGACTCCATAGCCGCCG 2481 CGTTCAGGCTGGAAAAGGCTTTTCAGCGGAGGGTGCTGTAACTGTCCAGCTGTGGGAGAGGAGATACCAGCCCAGGAGAA 2561 GAGCAGCTGGCCCTACTGGGCCTAGAAGTTTGGGAGACCCATCCCAGCAAGGATGGGAAATCAAGACAGATGTTGAGCAT 2641 GGATTTCCCAGAGGTGGTGACTGCGCCGCACAGAGGAGCATCTCTGCCTGGGAGGAGGGAGAGGGCTCCCGCCGGGCTGC 2721 CAGAGCCGAGCAAGTACCTGCACCTTCAGCCAGACACATGCTGGGCATTCTTCAGATGCCATCGTAAGGCGGAGGCCTGG 2801 GACGTCCCAGAACACCTATGGATGCTGCCCCTCGGGCTTTCTCGGCCACACCAGATGCAGAGGGGCTGTGGGAGCCTGGA 2881 AAAGGGCTTGGTGGTCCAGCTGCTTTGTTGTTGTTGTTTTTGTTTTGTTTGTTTGTTTGTTTGTTTGTTTTGGCTTGGGG 2961 CTTTTCTTAGAAGTGATGTGTTGTTAGAAACTTCAAACCAGATACAAATATACCCAACGAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 768239.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000319098.4 | 3UTR | AGGCACACUGGGCCUGAGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
65 hsa-miR-124-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT064177 | KIAA1804 | mitogen-activated protein kinase kinase kinase 21 | 2 | 2 | ||||||||
MIRT069736 | FOXG1 | forkhead box G1 | 2 | 4 | ||||||||
MIRT086429 | NABP1 | nucleic acid binding protein 1 | 2 | 6 | ||||||||
MIRT105334 | SLC7A2 | solute carrier family 7 member 2 | 2 | 4 | ||||||||
MIRT110455 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT172998 | YTHDF3 | YTH N6-methyladenosine RNA binding protein 3 | 2 | 2 | ||||||||
MIRT196428 | TAOK1 | TAO kinase 1 | 2 | 14 | ||||||||
MIRT325704 | CSTF2 | cleavage stimulation factor subunit 2 | 2 | 2 | ||||||||
MIRT365670 | TSC22D3 | TSC22 domain family member 3 | 2 | 4 | ||||||||
MIRT365873 | XIAP | X-linked inhibitor of apoptosis | 2 | 2 | ||||||||
MIRT404126 | ASB1 | ankyrin repeat and SOCS box containing 1 | 2 | 2 | ||||||||
MIRT404626 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT405284 | ARF1 | ADP ribosylation factor 1 | 2 | 2 | ||||||||
MIRT406099 | PAGR1 | PAXIP1 associated glutamate rich protein 1 | 2 | 2 | ||||||||
MIRT446627 | SDC3 | syndecan 3 | 2 | 2 | ||||||||
MIRT446906 | RGS5 | regulator of G protein signaling 5 | 2 | 2 | ||||||||
MIRT461790 | FXR2 | FMR1 autosomal homolog 2 | 2 | 2 | ||||||||
MIRT463982 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 4 | ||||||||
MIRT464204 | VGLL4 | vestigial like family member 4 | 2 | 2 | ||||||||
MIRT472790 | MTMR4 | myotubularin related protein 4 | 2 | 4 | ||||||||
MIRT473485 | MCFD2 | multiple coagulation factor deficiency 2 | 2 | 2 | ||||||||
MIRT481124 | AZIN1 | antizyme inhibitor 1 | 2 | 4 | ||||||||
MIRT485060 | SUCO | SUN domain containing ossification factor | 2 | 2 | ||||||||
MIRT487343 | HLA-DRA | major histocompatibility complex, class II, DR alpha | 2 | 2 | ||||||||
MIRT491948 | VPS52 | VPS52, GARP complex subunit | 2 | 2 | ||||||||
MIRT497208 | CDH7 | cadherin 7 | 2 | 2 | ||||||||
MIRT497476 | TOR1AIP2 | torsin 1A interacting protein 2 | 2 | 2 | ||||||||
MIRT528203 | NELFE | negative elongation factor complex member E | 2 | 2 | ||||||||
MIRT529255 | TRIM4 | tripartite motif containing 4 | 2 | 4 | ||||||||
MIRT530096 | PSAPL1 | prosaposin like 1 (gene/pseudogene) | 2 | 2 | ||||||||
MIRT530597 | C7orf33 | chromosome 7 open reading frame 33 | 2 | 4 | ||||||||
MIRT534980 | PSAT1 | phosphoserine aminotransferase 1 | 2 | 4 | ||||||||
MIRT538326 | CSGALNACT1 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | 2 | 2 | ||||||||
MIRT561237 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT562035 | KRAS | KRAS proto-oncogene, GTPase | 2 | 2 | ||||||||
MIRT563120 | THAP5 | THAP domain containing 5 | 2 | 2 | ||||||||
MIRT563538 | RBM41 | RNA binding motif protein 41 | 2 | 2 | ||||||||
MIRT566037 | REV3L | REV3 like, DNA directed polymerase zeta catalytic subunit | 2 | 2 | ||||||||
MIRT566505 | PAWR | pro-apoptotic WT1 regulator | 2 | 2 | ||||||||
MIRT566745 | MRPL35 | mitochondrial ribosomal protein L35 | 2 | 2 | ||||||||
MIRT566850 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT568077 | CELF2 | CUGBP Elav-like family member 2 | 2 | 2 | ||||||||
MIRT576826 | Tgfbr3 | transforming growth factor, beta receptor III | 2 | 2 | ||||||||
MIRT608870 | NR2E1 | nuclear receptor subfamily 2 group E member 1 | 2 | 4 | ||||||||
MIRT611997 | VAC14 | Vac14, PIKFYVE complex component | 2 | 2 | ||||||||
MIRT614054 | FAM89A | family with sequence similarity 89 member A | 2 | 2 | ||||||||
MIRT618800 | SPATA21 | spermatogenesis associated 21 | 2 | 2 | ||||||||
MIRT619389 | RSPH3 | radial spoke head 3 homolog | 2 | 2 | ||||||||
MIRT622282 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 2 | 2 | ||||||||
MIRT624026 | EN2 | engrailed homeobox 2 | 2 | 2 | ||||||||
MIRT626000 | MPEG1 | macrophage expressed 1 | 2 | 2 | ||||||||
MIRT641792 | USP32 | ubiquitin specific peptidase 32 | 2 | 2 | ||||||||
MIRT651599 | WDFY2 | WD repeat and FYVE domain containing 2 | 2 | 2 | ||||||||
MIRT659662 | CDC73 | cell division cycle 73 | 2 | 2 | ||||||||
MIRT663010 | KIAA1586 | KIAA1586 | 2 | 2 | ||||||||
MIRT663561 | ASTN2 | astrotactin 2 | 2 | 2 | ||||||||
MIRT669312 | C16orf72 | chromosome 16 open reading frame 72 | 2 | 2 | ||||||||
MIRT685216 | POTED | POTE ankyrin domain family member D | 2 | 2 | ||||||||
MIRT695757 | ZNF117 | zinc finger protein 117 | 2 | 2 | ||||||||
MIRT697909 | TXNRD1 | thioredoxin reductase 1 | 2 | 2 | ||||||||
MIRT707181 | RPH3A | rabphilin 3A | 2 | 2 | ||||||||
MIRT707214 | TRIM13 | tripartite motif containing 13 | 2 | 2 | ||||||||
MIRT707478 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | 2 | 2 | ||||||||
MIRT719507 | LMAN2L | lectin, mannose binding 2 like | 2 | 2 | ||||||||
MIRT755814 | PARP1 | poly(ADP-ribose) polymerase 1 | 2 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|